Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Crisis-driven cholera resurgence switches focus to oral vaccine.

[No authors listed]

Bull World Health Organ. 2018 Jul 1;96(7):446-447. doi: 10.2471/BLT.18.020718.

2.

Oral Cholera Vaccine Coverage during an Outbreak and Humanitarian Crisis, Iraq, 2015.

Lam E, Al-Tamimi W, Russell SP, Butt MO, Blanton C, Musani AS, Date K.

Emerg Infect Dis. 2017 Jan;23(1):38-45. doi: 10.3201/eid2301.160881.

3.

The cholera outbreak in Yemen: lessons learned and way forward.

Federspiel F, Ali M.

BMC Public Health. 2018 Dec 4;18(1):1338. doi: 10.1186/s12889-018-6227-6. Review.

4.

Cholera vaccine will reduce antibiotic use.

Okeke IN.

Science. 2009 Aug 7;325(5941):674. doi: 10.1126/science.325_674b. No abstract available.

PMID:
19661401
5.

Cholera, 2013.

[No authors listed]

Wkly Epidemiol Rec. 2014 Aug 1;89(31):345-55. English, French. No abstract available.

6.

Live oral vaccines against cholera: an update.

Levine MM, Kaper JB.

Vaccine. 1993;11(2):207-12. Review.

PMID:
8438619
7.

High hopes for oral cholera vaccine.

[No authors listed]

Bull World Health Organ. 2010 Mar;88(3):165-6. doi: 10.2471/BLT.10.010310. No abstract available.

8.

Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.

von Seidlein L, Deen JL.

Emerg Infect Dis. 2012 Jul;18(7):1211-4. doi: 10.3201/eid1807.120071. No abstract available.

9.

Cholera vaccines for the developing world.

Lopez AL, Clemens JD, Deen J, Jodar L.

Hum Vaccin. 2008 Mar-Apr;4(2):165-9. Epub 2007 Oct 7. Review.

PMID:
18414029
10.

Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up.

Clemens JD, Harris JR, Sack DA, Chakraborty J, Ahmed F, Stanton BF, Khan MU, Kay BA, Huda N, Khan MR, et al.

J Infect Dis. 1988 Jul;158(1):60-9.

PMID:
3392421
11.

Cholera vaccine faces major test in Yemen.

Kupferschmidt K.

Science. 2017 Jun 30;356(6345):1316-1317. doi: 10.1126/science.356.6345.1316. No abstract available.

PMID:
28663447
12.

Can oral cholera vaccination play a role in controlling a cholera outbreak?

Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL.

Vaccine. 2004 Jun 23;22(19):2444-51. Review.

PMID:
15193408
13.

Cholera in Yemen.

Balakrishnan VS.

Lancet Infect Dis. 2017 Jul;17(7):700-701. doi: 10.1016/S1473-3099(17)30352-3. Epub 2017 Jun 21. No abstract available.

PMID:
28737493
14.

Make plans to eliminate cholera outbreaks.

Zaidi A.

Nature. 2017 Oct 3;550(7674):9. doi: 10.1038/550009a. No abstract available.

PMID:
28980651
15.

Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.

Clemens JD, Sack DA, Rao MR, Chakraborty J, Khan MR, Kay B, Ahmed F, Banik AK, van Loon FP, Yunus M, et al.

J Infect Dis. 1992 Nov;166(5):1029-34.

PMID:
1402014
16.

Cholera vaccines: WHO position paper – August 2017.

[No authors listed]

Wkly Epidemiol Rec. 2017 Aug 25;92(34):477-98. English, French. No abstract available.

17.

Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea.

Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, Grais RF, Verhoustraeten F, Legros D.

PLoS Med. 2013;10(9):e1001512. doi: 10.1371/journal.pmed.1001512. Epub 2013 Sep 10. No abstract available.

18.

[Cholera update and vaccination problems].

Fournier JM, Villeneuve S.

Med Trop (Mars). 1998;58(2 Suppl):32-5. French.

PMID:
9812307
19.

Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.

Gupta SS, Bharati K, Sur D, Khera A, Ganguly NK, Nair GB.

Indian J Med Res. 2016 May;143(5):545-51. doi: 10.4103/0971-5916.187102. No abstract available.

20.

Use of Vibrio cholerae vaccine in an outbreak in Guinea.

Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Diallo AA, Itama C, Page AL, Quilici ML, Mengel MA, Eiros JM, Serafini M, Legros D, Grais RF.

N Engl J Med. 2014 May 29;370(22):2111-20. doi: 10.1056/NEJMoa1312680.

Supplemental Content

Support Center